Baycrest Health Sciences is a research and teaching hospital for the elderly in the North York district of Toronto, Ontario, Canada. It is fully affiliated with the University of Toronto.

During the past decade, Baycrest Health Sciences conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baycrest Health Sciences" #1 sponsor was "Baycrest" with 27 trials, followed by "Rotman Research Institute at Baycrest" with 3 trials sponsored, "Sunnybrook Health Sciences Centre" with 3 trials sponsored, "Anavex Life Sciences Corp." with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baycrest Health Sciences" #1 collaborator was "Baycrest" with 3 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator, "Sunnybrook Health Sciences Centre" with 3 trials as a collaborator, "Unity Health Toronto" with 3 trials as a collaborator and "University Health Network, Toronto" with 3 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Baycrest Health Sciences" are "Alzheimer Disease" (11 trials), "Mild Cognitive Impairment" (9 trials), "Aging" (7 trials), "Dementia" (4 trials) and "Primary Progressive Aphasia" (3 trials). Many other conditions were trialed in "Baycrest Health Sciences" in a lesser frequency.

Most popular intervention types in "Baycrest Health Sciences" are "Behavioral" (23 trials), "Drug" (10 trials), "Other" (8 trials), "Device" (6 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Brain Health PRO" (2 trials), "Control" (2 trials), "Gantenerumab" (2 trials) and "Goal Management Training" (2 trials). Other intervention names were less common.

The vast majority of trials in "Baycrest Health Sciences" are 48 trials for "All" genders.

Currently, there are NaN active trials in "Baycrest Health Sciences". 3 are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Baycrest Health Sciences, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Baycrest Health Sciences, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 32 trials that are defined as “Not Applicable".